These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21085722)

  • 1. Stability, accumulation and cytotoxicity of an albumin-cisplatin adduct.
    Møller C; Tastesen HS; Gammelgaard B; Lambert IH; Stürup S
    Metallomics; 2010 Dec; 2(12):811-8. PubMed ID: 21085722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
    J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
    Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
    Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin.
    Timerbaev AR; Aleksenko SS; Polec-Pawlak K; Ruzik R; Semenova O; Hartinger CG; Oszwaldowski S; Galanski M; Jarosz M; Keppler BK
    Electrophoresis; 2004 Jul; 25(13):1988-1995. PubMed ID: 15237398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R
    Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fortification of blood plasma from cancer patients with human serum albumin decreases the concentration of cisplatin-derived toxic hydrolysis products in vitro.
    Morris TT; Ruan Y; Lewis VA; Narendran A; Gailer J
    Metallomics; 2014 Nov; 6(11):2034-41. PubMed ID: 25255207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining TBP-based rOFFGEL-IEF with FASP and nLC-ESI-LTQ-MS/MS for the analysis of cisplatin-binding proteins in rat kidney.
    Moraleja I; Moreno-Gordaliza E; Mena ML; Gómez-Gómez MM
    Talanta; 2014 Mar; 120():433-42. PubMed ID: 24468393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective analysis of human serum albumin based on SEC-ICP-MS after labelling with iophenoxic acid.
    Dersch JM; Nguyen TT; Østergaard J; Stürup S; Gammelgaard B
    Anal Bioanal Chem; 2015 Apr; 407(10):2829-36. PubMed ID: 25650002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS.
    Hermann G; Heffeter P; Falta T; Berger W; Hann S; Koellensperger G
    Metallomics; 2013 Jun; 5(6):636-47. PubMed ID: 23487031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.
    Mistry P; Kelland LR; Loh SY; Abel G; Murrer BA; Harrap KR
    Cancer Res; 1992 Nov; 52(22):6188-93. PubMed ID: 1423261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.
    McDonald ES; Randon KR; Knight A; Windebank AJ
    Neurobiol Dis; 2005 Mar; 18(2):305-13. PubMed ID: 15686959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro.
    Sooriyaarachchi M; Narendran A; Gailer J
    Metallomics; 2011 Jan; 3(1):49-55. PubMed ID: 21135941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.
    Fichtinger-Schepman AM; van der Velde-Visser SD; van Dijk-Knijnenburg HC; van Oosterom AT; Baan RA; Berends F
    Cancer Res; 1990 Dec; 50(24):7887-94. PubMed ID: 2253228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
    Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
    Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
    Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.